181 Topical Sandalore®, a specific OR2AT4-stimulating odorant, ameliorates telogen effluvium: Randomized, double-blinded, placebo-controlled trial

Journal article

Peer reviewed

E Lopez, F Jimenez, M Bertolini, M.A Alam, C Ward, J Cheret, G Westgate, F Rinaldi and R Paus

Journal of investigative dermatology, Vol.139(9), pp.S245-S245

2019-09

Metrics

8 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 181 Topical Sandalore®, a specific OR2AT4-stimulating odorant, ameliorates telogen effluvium: Randomized, double-blinded, placebo-controlled trial
Creators: E Lopez - Mediteknia Clinic, Las Palmas, Spain
F Jimenez - Mediteknia Clinic, Las Palmas, Spain
M Bertolini - Monasterium Laboratory, Muenster, Germany
M.A Alam - Mediteknia Clinic, Las Palmas, Spain
C Ward - Monasterium Laboratory, Muenster, Germany
J Cheret - Miller School of Medicine, University of Miami, Miami, FL
G Westgate - Gill Westgate Consultancy, Stevington, United Kingdom
F Rinaldi - Giuliani Pharma, Milan, Italy
R Paus - Monasterium Laboratory, Muenster, Germany
Publication Details: Journal of investigative dermatology, Vol.139(9), pp.S245-S245
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Journal article
Record Identifier: 991031599312902976